Published: 24-09-2024
Review
WASOG 2023 conference highlights
Abstract 118 | PDF Downloads 84Page e2024046
Inhaled budesonide and pulmonary sarcoidosis revisited
Abstract 170 | PDF Downloads 124Page e2024037
Echocardiographic evaluation of left ventricular mechanics in sarcoidosis patients without overt heart disease: a systematic review and meta-analysis
Abstract 144 | PDF Downloads 107Page e2024042
Original Articles: Clinical Research
Scar sarcoidosis: Clinical features and prognostic significance
Abstract 132 | PDF Downloads 87Page e2024046
Central Nervous System Sarcoidosis: A National-Based registry study
Abstract 142 | PDF Downloads 104Page e2024040
Hydroxychloroquine monotherapy in sarcoidosis: Indications, efficacy, and side effects
Abstract 192 | PDF Downloads 130Page e2024039
Are the gains from pulmonary rehabilitation the same in idiopathic pulmonary fibrosis and other interstitial lung diseases?
Abstract 204 | PDF Downloads 208Page e2024038
Interstitial Lung Disease in Primary Sjögren’s Syndrome: Risk factors for occurrence and radiographic progression
Abstract 199 | PDF Downloads 166Page e2024035
The management of Familial Pulmonary Fibrosis in different medical settings: Where does that leave us? An Italian nationwide survey
Abstract 209 | PDF Downloads 140Page e2024047
Assessment of quality of life in IPF Patients: a multicenter observational study
Abstract 154 | PDF Downloads 108Page e2024043
Original Articles: Laboratory Research
Schisandrin B attenuates bleomycin-induced pulmonary fibrosis in mice through AKT-mTOR pathway
Abstract 137 | PDF Downloads 103Page e2024034
Case Reports
Case of familial interstitial lung disease attributed to ATP-binding cassette transporter 3 gene mutation in identical twins
Abstract 118 | PDF Downloads 131Page e2024033
Letter to Editor
The fissural involvement in pleuroparenchymal fibroelastosis: Something beyond the alveolar elastosis
Abstract 92 | PDF Downloads 72Page e2024041